BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 23302239)

  • 1. [Changes of choroidal thickness in central serous chorioretinopathy].
    Yang LH; Tian B; Shi XH; Ding N; Zhou D; Wei WB
    Zhonghua Yan Ke Za Zhi; 2012 Oct; 48(10):874-7. PubMed ID: 23302239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of fundus fluorescein angiography, indocyanine green angiography and choroidal thickness in central serous chorioretinopathy].
    Li L; Li DH; Yang ZK; Bian AL; Chen YX; Dong FT
    Zhonghua Yan Ke Za Zhi; 2012 Oct; 48(10):878-82. PubMed ID: 23302240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy.
    Maruko I; Iida T; Sugano Y; Ojima A; Sekiryu T
    Retina; 2011 Sep; 31(8):1603-8. PubMed ID: 21487334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy.
    Maruko I; Iida T; Sugano Y; Ojima A; Ogasawara M; Spaide RF
    Ophthalmology; 2010 Sep; 117(9):1792-9. PubMed ID: 20472289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choroidal thickness measurement by enhanced depth imaging and swept-source optical coherence tomography in central serous chorioretinopathy.
    Hamzah F; Shinojima A; Mori R; Yuzawa M
    BMC Ophthalmol; 2014 Nov; 14():145. PubMed ID: 25421855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Changes of Inner and Outer Choroid in Central Serous Chorioretinopathy Determined by Optical Coherence Tomography.
    Sonoda S; Sakamoto T; Kuroiwa N; Arimura N; Kawano H; Yoshihara N; Yamashita T; Uchino E; Kinoshita T; Mitamura Y
    PLoS One; 2016; 11(6):e0157190. PubMed ID: 27305042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy.
    Jirarattanasopa P; Ooto S; Tsujikawa A; Yamashiro K; Hangai M; Hirata M; Matsumoto A; Yoshimura N
    Ophthalmology; 2012 Aug; 119(8):1666-78. PubMed ID: 22521082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Choroidal thickness in both eyes of patients with unilaterally active central serous chorioretinopathy.
    Kim YT; Kang SW; Bai KH
    Eye (Lond); 2011 Dec; 25(12):1635-40. PubMed ID: 22020172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CHOROIDAL THICKNESS IN PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY: Assessment of Haller and Sattler Layers.
    Chung YR; Kim JW; Kim SW; Lee K
    Retina; 2016 Sep; 36(9):1652-7. PubMed ID: 26934451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biometric characteristics of eyes with central serous chorioretinopathy.
    Oh JH; Oh J; Togloom A; Kim SW; Huh K
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1502-8. PubMed ID: 24550360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PERIPAPILLARY CHOROIDAL THICKNESS IN CENTRAL SEROUS CHORIORETINOPATHY: Is Choroid Outside the Macula Also Thick?
    Yun C; Oh J; Han JY; Hwang SY; Moon SW; Huh K
    Retina; 2015 Sep; 35(9):1860-6. PubMed ID: 25874368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choroidal thickness in central serous chorioretinopathy.
    Kuroda S; Ikuno Y; Yasuno Y; Nakai K; Usui S; Sawa M; Tsujikawa M; Gomi F; Nishida K
    Retina; 2013 Feb; 33(2):302-8. PubMed ID: 23064424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optical coherence tomography-assisted enhanced depth imaging of central serous chorioretinopathy.
    Yang L; Jonas JB; Wei W
    Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4659-65. PubMed ID: 23737472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Choroidal thickness after half-dose verteporfin photodynamic therapy in chronic central serous chorioretinopathy].
    Zeng J; Yan YY; Ding XY; Liu R; Li JQ
    Zhonghua Yan Ke Za Zhi; 2013 Jun; 49(6):490-4. PubMed ID: 24119960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy.
    Maruko I; Iida T; Sugano Y; Furuta M; Sekiryu T
    Retina; 2011 Oct; 31(9):1921-7. PubMed ID: 21878850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subfoveal Choroidal Thickness in Central Serous Chorioretinopathy: A Meta-Analysis.
    Chen G; Tzekov R; Li W; Jiang F; Mao S; Tong Y
    PLoS One; 2017; 12(1):e0169152. PubMed ID: 28076442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choroidal thickness measurements during central serous chorioretinopathy treatment.
    Brandl C; Helbig H; Gamulescu MA
    Int Ophthalmol; 2014 Feb; 34(1):7-13. PubMed ID: 23572440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in Choroidal Structures in Eyes with Chronic Central Serous Chorioretinopathy after Half-Dose Photodynamic Therapy.
    Kinoshita T; Mitamura Y; Mori T; Akaiwa K; Semba K; Egawa M; Mori J; Sonoda S; Sakamoto T
    PLoS One; 2016; 11(9):e0163104. PubMed ID: 27636093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choroidal thickness following extrafoveal photodynamic treatment with verteporfin in patients with central serous chorioretinopathy.
    Pryds A; Larsen M
    Acta Ophthalmol; 2012 Dec; 90(8):738-43. PubMed ID: 21586096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choroidal vessel diameter in central serous chorioretinopathy.
    Yang L; Jonas JB; Wei W
    Acta Ophthalmol; 2013 Aug; 91(5):e358-62. PubMed ID: 23647989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.